搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Glycosyltransferase-like protein LARGE (lge-1), partial CSB-YP636380CXY
CSB-EP636380CXY
CSB-BP636380CXY
CSB-MP636380CXY
CSB-EP636380CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Methylenetetrahydrofolate--tRNA- (uracil-5-)-methyltransferase TrmFO (trmFO) CSB-YP636381RAAK
CSB-EP636381RAAK
CSB-BP636381RAAK
CSB-MP636381RAAK
CSB-EP636381RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lipoyl synthase, mitochondrial (M01F1.3), partial CSB-YP636382CXY
CSB-EP636382CXY
CSB-BP636382CXY
CSB-MP636382CXY
CSB-EP636382CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Serine hydroxymethyltransferase (glyA) CSB-YP636383RAAK
CSB-EP636383RAAK
CSB-BP636383RAAK
CSB-MP636383RAAK
CSB-EP636383RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris UPF0271 protein RPC_2622 (RPC_2622) CSB-YP636384RAAK
CSB-EP636384RAAK
CSB-BP636384RAAK
CSB-MP636384RAAK
CSB-EP636384RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Putative pterin-4-alpha-carbinolamine dehydratase (RPC_2524) CSB-YP636385RAAK
CSB-EP636385RAAK
CSB-BP636385RAAK
CSB-MP636385RAAK
CSB-EP636385RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant MOG interacting and ectopic P-granules protein 1 (mep-1), partial CSB-YP636386CXY
CSB-EP636386CXY
CSB-BP636386CXY
CSB-MP636386CXY
CSB-EP636386CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NHP2-like protein 1 homolog (M28.5) CSB-YP636387CXY
CSB-EP636387CXY
CSB-BP636387CXY
CSB-MP636387CXY
CSB-EP636387CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris LexA repressor (lexA) CSB-YP636388RAAK
CSB-EP636388RAAK
CSB-BP636388RAAK
CSB-MP636388RAAK
CSB-EP636388RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Elongation factor Ts (tsf) CSB-YP636389RAAK
CSB-EP636389RAAK
CSB-BP636389RAAK
CSB-MP636389RAAK
CSB-EP636389RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris NADH-quinone oxidoreductase subunit C (nuoC) CSB-YP636390RAAK
CSB-EP636390RAAK
CSB-BP636390RAAK
CSB-MP636390RAAK
CSB-EP636390RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP636391RAAK
CSB-EP636391RAAK
CSB-BP636391RAAK
CSB-MP636391RAAK
CSB-EP636391RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris 30S ribosomal protein S18 (rpsR) CSB-YP636392RAAK
CSB-EP636392RAAK
CSB-BP636392RAAK
CSB-MP636392RAAK
CSB-EP636392RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP636393RAAK1
CSB-EP636393RAAK1
CSB-BP636393RAAK1
CSB-MP636393RAAK1
CSB-EP636393RAAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative N (4)- (beta-N-acetylglucosaminyl)-L-asparaginase (R04B3.2) CSB-YP636394CXY
CSB-EP636394CXY
CSB-BP636394CXY
CSB-MP636394CXY
CSB-EP636394CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Trans-aconitate 2-methyltransferase (tam) CSB-YP636395RAAK
CSB-EP636395RAAK
CSB-BP636395RAAK
CSB-MP636395RAAK
CSB-EP636395RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Ribose-5-phosphate isomerase A (rpiA) CSB-YP636396RAAK
CSB-EP636396RAAK
CSB-BP636396RAAK
CSB-MP636396RAAK
CSB-EP636396RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Germ cell-expressed protein R06C7.1 (R06C7.1), partial CSB-YP636397CXY
CSB-EP636397CXY
CSB-BP636397CXY
CSB-MP636397CXY
CSB-EP636397CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Formyl-coenzyme A transferase (frc) CSB-YP636398RAAK
CSB-EP636398RAAK
CSB-BP636398RAAK
CSB-MP636398RAAK
CSB-EP636398RAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein R102.4 (R102.4) CSB-YP636399CXY
CSB-EP636399CXY
CSB-BP636399CXY
CSB-MP636399CXY
CSB-EP636399CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>